ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,204.53
0.30%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Assembly Biosciences Inc (ASMB)

  7. Assembly Biosciences Inc (ASMB) News

Assembly Biosciences (ASMB)

Assembly Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ASMB
DateTimeSourceHeadlineSymbolCompany
10/06/202413:00GlobeNewswire Inc.Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366NASDAQ:ASMBAssembly Biosciences Inc
05/06/202413:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024NASDAQ:ASMBAssembly Biosciences Inc
03/06/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
30/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
30/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
30/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
24/05/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
24/05/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
24/05/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
24/05/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
22/05/202413:00GlobeNewswire Inc.Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congress™ 2024NASDAQ:ASMBAssembly Biosciences Inc
08/05/202421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
08/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
08/05/202421:05GlobeNewswire Inc.Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
28/03/202420:05GlobeNewswire Inc.Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent HighlightsNASDAQ:ASMBAssembly Biosciences Inc
08/02/202413:00GlobeNewswire Inc.Assembly Biosciences Announces Effective Date of Reverse Stock SplitNASDAQ:ASMBAssembly Biosciences Inc
02/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
19/01/202416:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
17/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
04/01/202413:00GlobeNewswire Inc.Assembly Biosciences Provides Anticipated Development Milestones for 2024NASDAQ:ASMBAssembly Biosciences Inc
21/12/202321:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ASMBAssembly Biosciences Inc
21/12/202321:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202321:10Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ASMBAssembly Biosciences Inc
11/12/202321:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
07/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ASMBAssembly Biosciences Inc
22/11/202321:12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ASMBAssembly Biosciences Inc
22/11/202321:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ASMBAssembly Biosciences Inc
10/11/202321:05GlobeNewswire Inc.Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ASMBAssembly Biosciences Inc
10/11/202313:00GlobeNewswire Inc.Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®NASDAQ:ASMBAssembly Biosciences Inc
08/11/202321:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ASMBAssembly Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ASMB

Your Recent History

LSE
PANR
Pantheon Resources
LSE
AAZ
Anglo Asian Mining
LSE
SBTX
Skinbiotherapeutics
LSE
VOD
Vodafone
LSE
GOLD
LSE
INSG
Insig Ai
LSE
ENET
Ethernity Networks
LSE
BATS
British American Tobacco
LSE
HUM
Hummingbird Resources
LSE
SDRY
Superdry
LSE
GPM
Golden Prospect Precious...
LSE
EEE
Empire Metals
LSE
SRSP
Sirius Petroleum
LSE
PHNX
Phoenix
LSE
BIRD
Blackbird
LSE
HE1
Helium One Global
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved